Board of Directors

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.

Giovanni Caforio

Giovanni Caforio, M.D.

Chairman of the Board and Chief Executive Officer, Bristol Myers Squibb 

Vicki L. Sato

Vicki L. Sato, Ph.D.

Lead Independent Director, Bristol Myers Squibb and Chairman of the Board, Denali Therapeutics, Inc.

Peter J.  Arduini

Peter J. Arduini

President and Chief Executive Officer of Integra LifeSciences Holdings Corporation

Robert Bertolini

Robert Bertolini

Former President and Chief Financial Officer of Bausch & Lomb Incorporated

Michael W. Bonney

Michael W. Bonney

Executive Chair, Kaleido Biosciences, Inc.

 Matthew W. Emmens

Matthew W. Emmens

Retired Chief Executive Officer and Chairman of the Board of Shire PLC

Julia A. Haller, M.D.

Julia A. Haller, M.D.

Ophthalmologist-in-Chief, Wills Eye Hospital

Dinesh C. Paliwal

Dinesh C. Paliwal

President and Chief Executive Officer, Harman International

Paula A. Price

Paula A. Price

Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.

Derica W. Rice

Derica W. Rice

Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark.

Theodore R. Samuels

Theodore R. Samuels

Retired President of Capital Guardian Trust Company

Gerald L. Storch

Gerald L. Storch

Chief Executive Officer, Storch Advisors

Karen H. Vousden, Ph.D.

Karen H. Vousden, Ph.D.

Senior Group Leader, The Francis Crick Institute and Chief Scientist, Cancer Research UK

Phyllis R. Yale

Phyllis R. Yale

Advisory Partner, Bain & Company